Lung Cancer Surgery Market Report 2026

Lung Cancer Surgery Market Overview

• Lung Cancer Surgery market size has reached to $5.33 billion in 2025 • Expected to grow to $6.73 billion in 2030 at a compound annual growth rate (CAGR) of 4.7% • Growth Driver: Increasing Incidence Of Lung Cancer Fueling The Growth Of The Market Due To Rising Need For Surgical Intervention In Early-Stage Diagnoses • Market Trend: Johnson & Johnson MedTech Advances Lung Cancer Diagnosis With MONARCH QUEST Robotic-Assisted Bronchoscopy Platform • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Lung Cancer Surgery Market?

Lung cancer surgery is a medical procedure to remove cancerous tissue from the lungs. It is typically performed when the cancer is confined to the lung and has not spread widely. The goal of the surgery is to remove the tumor completely and affected lung tissue to prevent the cancer from progressing or recurring. The main types of lung cancer surgery are thoracotomy and minimally invasive surgeries. A thoracotomy is a surgical procedure in which the doctor makes an incision in the chest wall to access the lungs or other organs in the chest. The various procedures involved are lobectomy, segmentectomy, pneumonectomy, sleeve resection, and extended resection, performed using different products such as thoracoscopes, mediastinoscopes, bronchoscopes, robotic-assisted thoracic surgery systems, surgical staplers, surgical energy instruments, advanced energy instruments, advanced bipolar instruments, ultrasonic instruments, and others. They are distributed through multiple channels, including direct tender, retail sales, online sales, and others. The key end users include hospitals, ambulatory and surgical centers, academic and research institutes, specialty cancer care centers, and others.

What Is The Lung Cancer Surgery Market Growth Forecast?

The lung cancer surgery market size is expected to see steady growth in the next few years. It will grow to $6.73 billion in 2030 at a compound annual growth rate (CAGR) of 4.7%. The growth in the forecast period can be attributed to increasing integration of robotic surgery platforms, rising demand for precision surgical outcomes, expansion of specialized cancer care centers, growing investments in surgical technology, increasing adoption of enhanced recovery after surgery protocols. Major trends in the forecast period include increasing adoption of minimally invasive surgical techniques, rising use of robotic-assisted thoracic surgery, growing preference for lung-preserving procedures, expansion of advanced surgical instrument utilization, enhanced focus on post-surgical recovery outcomes.

Global Lung Cancer Surgery Market Segmentation

1) By Surgical Approach: Thoracotomy, Minimally Invasive Surgeries 2) By Procedure: Lobectomy, Segmentectomy, Pneumonectomy, Sleeve Resection, Extended Reserction 3) By Product: Thoracoscopes, Mediastinoscopes, Bronchoscopes, Robotic-Assistes Thoracic Surgery Systems, Surgical Staplers, Surgical Energy Instruments, Advanced Energy Instruments, Advanced Bipolar Instruments, Ultrasonic Instruments 4) By Distribution Channels: Direct Tender, Retail Sales, Online Sales, Other Channels 5) By End User: Hospitals, Ambulatory And Surgical Centres, Academic And Research Institutes, Specialiaty Cancer Care Centre, Other End Users Subsegments: 1) By Thoracotomy: Lobectomy, Pneumonectomy, Segmentectomy, Wedge Resection 2) By Minimally Invasive Surgeries: Video-Assisted Thoracoscopic Surgery (VATS), Robotic-Assisted Surgery

What Is The Driver Of The Lung Cancer Surgery Market?

The increasing incidence of lung cancer is expected to propel the growth of the lung cancer surgery market going forward. Lung cancer is the uncontrolled growth of abnormal cells in one or both lungs, which can interfere with normal lung function. The increasing incidence of lung cancer is due to prolonged exposure to air pollution, excellent particulate matter, as these tiny particles can penetrate deep into the lungs, causing inflammation, cellular damage, and mutations that can lead to cancer development. Lung cancer surgery helps reduce the incidence of lung cancer-related deaths by enabling early removal of malignant tumors before they can spread or progress. For instance, in June 2025, according to the Centers for Disease Control and Prevention, a US-based federal government agency, in 2023, lung cancer was responsible for 131,584 deaths in the United States, following 218,893 newly reported cases in 2022. Therefore, the increasing incidence of lung cancer is propelling the growth of the lung cancer surgery industry.

Key Players In The Global Lung Cancer Surgery Market

Major companies operating in the lung cancer surgery market are Johnson And Johnson, Medtronic plc, Fujifilm Holdings Corporation, B Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc, Teleflex Incorporated, Karl Storz SE, Lepu Medical Technology Beijing Co Ltd, Ambu AS, KLS Martin Group, Richard Wolf GmbH, Ethicon Inc, Ackermann Instrument GmbH, Scanlan International Inc, Sontec Instruments Inc, Covidien LLC, Stryker Corporation, Smith And Nephew plc, CONMED Corporation, Erbe Elektromedizin GmbH

Global Lung Cancer Surgery Market Trends and Insights

Major companies operating in the lung cancer surgery market are focusing on developing innovative technologies, such as robotic-assisted surgeries, to enhance surgical precision, reduce recovery time, and improve patient outcomes. Robotic-assisted surgeries refer to minimally invasive procedures performed using robotic systems controlled by surgeons to enhance precision, reduce complications, and improve patient recovery outcomes. For instance, in March 2025, Johnson & Johnson MedTech, a US-based medical devices and technology company, announced the regulatory clearance of MONARCH QUEST under U.S. 510(k). The MONARCH QUEST robotic-assisted bronchoscopy platform offers enhanced reach and stability to access small, hard-to-reach lung nodules, improving the ability to diagnose lung cancer at earlier stages. Its advanced maneuverability and integration with imaging technologies allow for more accurate biopsies while minimizing patient discomfort. It is designed to expand procedural capabilities and streamline workflow; the platform supports greater clinical confidence and consistency across a wider range of bronchoscopic procedures.

What Are Latest Mergers And Acquisitions In The Lung Cancer Surgery Market?

In June 2023, AstraZeneca Pharma India Ltd., an India-based pharmaceutical manufacturing company, partnered with Rajiv Gandhi Cancer Institute and Research Center to enhance lung cancer diagnostic capabilities by establishing a Center of Excellence to advance early and precise testing. This partnership aims to improve patient outcomes by enabling timely diagnosis, promoting access to advanced testing technologies, and supporting personalized treatment approaches for lung cancer. Rajiv Gandhi Cancer Institute and Research Center is an India-based company that offers thoracic surgery services, including minimally invasive techniques such as video-assisted thoracoscopic surgery (VATS) and robotic surgery for lung cancer.

Regional Outlook

North America was the largest region in the lung cancer surgery market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lung Cancer Surgery Market?

The lung cancer surgery market consists of revenues earned by entities providing services such as preoperative and postoperative care, follow-up and monitoring and surgical procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The lung cancer surgery market includes sales of products such as surgical instruments, stapling devices, electrosurgical units, thoracoscopes, and robotic surgical systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Lung Cancer Surgery Market Report 2026?

The lung cancer surgery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer surgery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.